Omnicare to pay $8M to settle false claims allegations in 28 states

Listen
Text
  • Small
  • Medium
  • Large

Omnicare, a pharmacy services provider owned by Woonsocket, R.I.-based CVS Health, has agreed to pay 28 states a combined $8 million to resolve allegations it violated the False Claims Act, according to the Department of Justice.

The government alleged Omnicare implemented an automated label verification system at certain locations that used less specific drug codes than the National Drug Code — a 10-digit number that identifies the labeler, product and trade package size. The use of less specific drug codes resulted in Omnicare submitting claims to Medicare and Medicaid for generic drugs that were not actually dispensed to beneficiaries, according to the DOJ.

The government also alleged Omnicare dispensed drugs with labels that displayed the incorrect manufacturer or National Drug Code.

The allegations against Omnicare were originally brought in a lawsuit filed under the qui tam, or whistle-blower, provisions of the False Claims Act.

More articles on healthcare industry lawsuits:

Florida physician convicted on 67 counts of Medicare fraud
IU Health, HealthNet pay $18M to resolve false billing allegations
Partners, Brigham and Women's to pay $10M to settle research fraud suit

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars